[1] Collaborative Group on Hormonal Factors in Breast Cancer (2001). Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet (London, England), 358(9291), 1389–1399. https://doi.org/10.1016/S0140-6736(01)06524-2
[2] Antoniou, A. C., & Easton, D. F. (2006). Models of genetic susceptibility to breast cancer. Oncogene, 25(43), 5898–5905. https://doi.org/10.1038/sj.onc.1209879
[3] Rudolph, A., Song, M., Brook, M. N., Milne, R. L., Mavaddat, N., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Wilcox, A. N., Hopper, J. L., Southey, M. C., Keeman, R., Fasching, P. A., Beckmann, M. W., Gago-Dominguez, M., Castelao, J. E., Guénel, P., Truong, T., Bojesen, S. E et al. (2018). Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. International journal of epidemiology, 47(2), 526–536. https://doi.org/10.1093/ije/dyx242
[4] Miñambres R., Pita G., Sánchez I., Serra D., Rosa R., Rubio-Solsona E., Palacios S., Llaneza A., Marron P., Hoyas S., Lluch A., Cano A., González A., Triviño JC., Benítez J (2019) Prediction of cancer risk based on study of genetic variants in healthy women in the Spanish population. Revista de Senología y Patología Mamaria, Vol 32 (3): 94-99.https://doi.org/10.1016/j.senol.2019.07.001
[5] Mavaddat, N., Pharoah, P. D., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., Wang, Q., Dennis, J., Dunning, A. M., Shah, M., Luben, R., Brown, J., Bojesen, S. E., Nordestgaard, B. G., Nielsen, S. F., Flyger, H., Czene, K., Darabi, H., Eriksson, M., Peto J et al (2015). Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute, 107(5), djv036. https://doi.org/10.1093/jnci/djv036
[6] Vachon, C. M., Scott, C. G., Tamimi, R. M., Thompson, D. J., Fasching, P. A., Stone, J., Southey, M. C., Winham, S., Lindström, S., Lilyquist, J., Giles, G. G., Milne, R. L., MacInnis, R. J., Baglietto, L., Li, J., Czene, K., Bolla, M. K., Wang, Q., Dennis, J., Haeberle, L et al (2019). Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast cancer research: BCR, 21(1), 68. https://doi.org/10.1186/s13058-019-1138-8
[7] Lee, A., Mavaddat, N., Wilcox, A. N., Cunningham, A. P., Carver, T., Hartley, S., Babb de Villiers, C., Izquierdo, A., Simard, J., Schmidt, M. K., Walter, F. M., Chatterjee, N., Garcia-Closas, M., Tischkowitz, M., Pharoah, P., Easton, D. F., & Antoniou, A. C. (2019). BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in medicine : official journal of the American College of Medical Genetics, 21(8), 1708–1718. https://doi.org/10.1038/s41436-018-0406-9
[8] Pollán, M., Ascunce, N., Ederra, M., Murillo, A., Erdozáin, N., Alés-Martínez, J., & Pastor-Barriuso, R. (2013). Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast cancer research : BCR, 15(1), R9. https://doi.org/10.1186/bcr3380
[9] Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R. L., Schmidt, M. K., Chang-Claude, J., Bojesen, S. E., Bolla, M. K., Wang, Q., Dicks, E., Lee, A., Turnbull, C., Rahman, N., Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher, O., Peto, J., Gibson, L., Dos Santos Silva, I et al (2013). Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature genetics, 45(4), 353–361e3612. https://doi.org/10.1038/ng.2563
[10] Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., Maranian, M. J., Bolla, M. K., Wang, Q., Shah, M., Perkins, B. J., Czene, K., Eriksson, M., Darabi, H., Brand, J. S., Bojesen, S. E., Nordestgaard, B. G., Flyger, H., Nielsen, S. F., Rahman, N et al (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature genetics, 47(4), 373–380. https://doi.org/10.1038/ng.3242
[11] Ghoussaini, M., Pharoah, P., & Easton, D. F. (2013). Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?. The American journal of pathology, 183(4), 1038–1051. https://doi.org/10.1016/j.ajpath.2013.07.003
[12] Michailidou, K., Lindström, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemaçon, A., Soucy, P., Glubb, D., Rostamianfar, A., Bolla, M. K., Wang, Q., Tyrer, J., Dicks, E., Lee, A., Wang, Z., Allen, J., Keeman, R., Eilber, U., French, J. D et al (2017). Association analysis identifies 65 new breast cancer risk loci. Nature, 551(7678), 92–94. https://doi.org/10.1038/nature24284
[13] Osorio, A., Milne, R. L., Kuchenbaecker, K., Vaclová, T., Pita, G., Alonso, R., Peterlongo, P., Blanco, I., de la Hoya, M., Duran, M., Díez, O., Ramón Y Cajal, T., Konstantopoulou, I., Martínez-Bouzas, C., Andrés Conejero, R., Soucy, P., McGuffog, L., Barrowdale, D., Lee, A., SWE-BRCA et al (2014). DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS genetics, 10(4), e1004256. https://doi.org/10.1371/journal.pgen.1004256
[14] Gaudet, M. M., Kuchenbaecker, K. B., Vijai, J., Klein, R. J., Kirchhoff, T., McGuffog, L., Barrowdale, D., Dunning, A. M., Lee, A., Dennis, J., Healey, S., Dicks, E., Soucy, P., Sinilnikova, O. M., Pankratz, V. S., Wang, X., Eldridge, R. C., Tessier, D. C., Vincent, D., Bacot, F et al (2013). Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS genetics, 9(3), e1003173. https://doi.org/10.1371/journal.pgen.1003173
[15] Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K. B., Soucy, P., Fredericksen, Z., Barrowdale, D., Dennis, J., Gaudet, M. M., Dicks, E., Kosel, M., Healey, S., Sinilnikova, O. M., Lee, A., Bacot, F., Vincent, D., Hogervorst, F. B., Peock, S et al (2013). Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS genetics, 9(3), e1003212. https://doi.org/10.1371/journal.pgen.1003212
[16] Bojesen, S. E., Pooley, K. A., Johnatty, S. E., Beesley, J., Michailidou, K., Tyrer, J. P., Edwards, S. L., Pickett, H. A., Shen, H. C., Smart, C. E., Hillman, K. M., Mai, P. L., Lawrenson, K., Stutz, M. D., Lu, Y., Karevan, R., Woods, N., Johnston, R. L., French, J. D., Chen, X et al (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature genetics, 45(4), 371–384e3842. https://doi.org/10.1038/ng.2566
[17] Pharoah, P. D., Antoniou, A. C., Easton, D. F., & Ponder, B. A. (2008). Polygenes, risk prediction, and targeted prevention of breast cancer. The New England journal of medicine, 358(26), 2796–2803. https://doi.org/10.1056/NEJMsa0708739
[18] Pharoah PD., Day NE., Duffy S., Easton DF., Ponder BA. (1997) Family history and the risk of breast cancer: a systematic review and metaanalysis. Int J Cancer;71(5):800-9.
[19] Maas, P., Barrdahl, M., Joshi, A. D., Auer, P. L., Gaudet, M. M., Milne, R. L., Schumacher, F. R., Anderson, W. F., Check, D., Chattopadhyay, S., Baglietto, L., Berg, C. D., Chanock, S. J., Cox, D. G., Figueroa, J. D., Gail, M. H., Graubard, B. I., Haiman, C. A., Hankinson, S. E., Hoover, R. N et al (2016). Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. JAMA oncology, 2(10), 1295–1302. https://doi.org/10.1001/jamaoncol.2016.1025
[20] Jeffrey Hughes (2020). reghelper: Helper Functions for Regression Analysis. R package version 0.3.5.
[21] Draper, N.R., Smith, H., (1998). Applied Regression Analysis. New York, John Wiley & Sons
[22] Hosmer DW, Lemeshow S, Sturdivant RX., (2013) Applied logistic regression. 3rd ed. New York: Wiley
[23] Rosner, B., & Glynn, R. J. (2009). Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics, 65(1), 188–197. https://doi.org/10.1111/j.1541-0420.2008.01062.x
[24] Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J. C., & Müller, M. (2011). pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics, 12, 77. https://doi.org/10.1186/1471-2105-12-77
[25] Tworoger, S. S., Zhang, X., Eliassen, A. H., Qian, J., Colditz, G. A., Willett, W. C., Rosner, B. A., Kraft, P., & Hankinson, S. E. (2014). Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(28), 3111–3117. https://doi.org/10.1200/JCO.2014.56.1068
[26] Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer Statistics, 2017. CA: a cancer journal for clinicians, 67(1), 7–30. https://doi.org/10.3322/caac.21387
[27] Bertrand, K. A., Tamimi, R. M., Scott, C. G., Jensen, M. R., Pankratz, V., Visscher, D., Norman, A., Couch, F., Shepherd, J., Fan, B., Chen, Y. Y., Ma, L., Beck, A. H., Cummings, S. R., Kerlikowske, K., & Vachon, C. M. (2013). Mammographic density and risk of breast cancer by age and tumor characteristics. Breast cancer research : BCR, 15(6), R104. https://doi.org/10.1186/bcr3570
[28] Tice, J. A., Miglioretti, D. L., Li, C. S., Vachon, C. M., Gard, C. C., & Kerlikowske, K. (2015). Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(28), 3137–3143. https://doi.org/10.1200/JCO.2015.60.8869
[29] Hsieh, C. C., Trichopoulos, D., Katsouyanni, K., & Yuasa, S. (1990). Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. International journal of cancer, 46(5), 796–800. https://doi.org/10.1002/ijc.2910460508
[30] Shieh, Y., Hu, D., Ma, L., Huntsman, S., Gard, C. C., Leung, J., Tice, J. A., Ziv, E., Kerlikowske, K., & Cummings, S. R. (2017). Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast cancer research and treatment, 166(2), 603–612. https://doi.org/10.1007/s10549-017-4430-2
[31] Dite, G. S., MacInnis, R. J., Bickerstaffe, A., Dowty, J. G., Allman, R., Apicella, C., Milne, R. L., Tsimiklis, H., Phillips, K. A., Giles, G. G., Terry, M. B., Southey, M. C., & Hopper, J. L. (2016). Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 25(2), 359–365. https://doi.org/10.1158/1055-9965.EPI-15-0838
[32] Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., Tyrer, J. P., Chen, T. H., Wang, Q., Bolla, M. K., Yang, X., Adank, M. A., Ahearn, T., Aittomäki, K., Allen, J., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Aronson, K. J et al (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American journal of human genetics, 104(1), 21–34. https://doi.org/10.1016/j.ajhg.2018.11.002
[33] Van Veen, E. M., Brentnall, A. R., Byers, H., Harkness, E. F., Astley, S. M., Sampson, S., Howell, A., Newman, W. G., Cuzick, J., & Evans, D. (2018). Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. JAMA oncology, 4(4), 476–482. https://doi.org/10.1001/jamaoncol.2017.4881
[34] Hüsing, A., Canzian, F., Beckmann, L., Garcia-Closas, M., Diver, W. R., Thun, M. J., Berg, C. D., Hoover, R. N., Ziegler, R. G., Figueroa, J. D., Isaacs, C., Olsen, A., Viallon, V., Boeing, H., Masala, G., Trichopoulos, D., Peeters, P. H., Lund, E., Ardanaz, E., Khaw, K. T et al (2012). Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. Journal of medical genetics, 49(9), 601–608. https://doi.org/10.1136/jmedgenet-2011-100716
[35] Yanes, T., Young, M. A., Meiser, B., & James, P. A. (2020). Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field. Breast cancer research : BCR, 22(1), 21. https://doi.org/10.1186/s13058-020-01260-3
[36] Tice, J. A., Cummings, S. R., Smith-Bindman, R., Ichikawa, L., Barlow, W. E., & Kerlikowske, K. (2008). Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Annals of internal medicine, 148(5), 337–347. https://doi.org/10.7326/0003-4819-148-5-200803040-00004
[37] Tice, J. A., Miglioretti, D. L., Li, C. S., Vachon, C. M., Gard, C. C., & Kerlikowske, K. (2015). Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(28), 3137–3143. https://doi.org/10.1200/JCO.2015.60.8869
[38] Collaborative Group on Hormonal Factors in Breast Cancer (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet. Oncology, 13(11), 1141–1151. https://doi.org/10.1016/S1470-2045(12)70425-4
[39] J. M., Castaño-Vinyals, G., Martín-Sanchez, V., Gómez-Acebo, I., Guevara, M., Tardón, A., Pérez-Gómez, B., Amiano, P., Moreno, V., Molina, A. J., Alonso-Molero, J., Moreno-Iribas, C., Kogevinas, M., Pollán, M., & Llorca, J. (2018). Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project. BMC cancer, 18(1), 280. https://doi.org/10.1186/s12885-018-4182-3
[40] Zhang, X., Rice, M., Tworoger, S. S., Rosner, B. A., Eliassen, A. H., Tamimi, R. M., Joshi, A. D., Lindstrom, S., Qian, J., Colditz, G. A., Willett, W. C., Kraft, P., & Hankinson, S. E. (2018). Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS medicine, 15(9), e1002644. https://doi.org/10.1371/journal.pmed.1002644